Denosumab in early breast cancer: negative data and a call to action

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)5-6
Number of pages2
JournalThe Lancet Oncology
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2020

ASJC Scopus subject areas

  • Oncology

Cite this

Denosumab in early breast cancer : negative data and a call to action. / Perrone, Francesco; Gravina, Adriano.

In: The Lancet Oncology, Vol. 21, No. 1, 01.2020, p. 5-6.

Research output: Contribution to journalComment/debate

@article{e608bf7a13374fa8a2e34e1373b14764,
title = "Denosumab in early breast cancer: negative data and a call to action",
author = "Francesco Perrone and Adriano Gravina",
year = "2020",
month = "1",
doi = "10.1016/S1470-2045(19)30717-X",
language = "English",
volume = "21",
pages = "5--6",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

TY - JOUR

T1 - Denosumab in early breast cancer

T2 - negative data and a call to action

AU - Perrone, Francesco

AU - Gravina, Adriano

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85077147869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077147869&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30717-X

DO - 10.1016/S1470-2045(19)30717-X

M3 - Comment/debate

C2 - 31806541

AN - SCOPUS:85077147869

VL - 21

SP - 5

EP - 6

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 1

ER -